Enamel Matrix Derivative and Xenograft for Mandibular Molar Furcation Defects

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City

About this trial

This randomized controlled clinical trial aims to compare two regenerative surgical approaches for the treatment of mandibular molar Class II furcation defects in patients with periodontitis. Eligible furcation defects will be randomly assigned to receive either xenograft bone combined with enamel matrix derivative (EMD) or xenograft bone combined with a collagen membrane. Both approaches are used to support periodontal tissue regeneration.

Participants will be followed for approximately 7 months. The study will evaluate postoperative pain and patient-reported satisfaction, periodontal clinical parameters, changes in furcation defect volume and relative bone density on cone-beam computed tomography (CBCT), and changes in gingival crevicular fluid TWEAK levels. Clinical and radiographic outcomes will be assessed before surgery and during follow-up, including at 3 and 6 months after surgery.

The study is intended to determine whether xenograft bone combined with EMD provides clinical, radiographic, biological, and patient-reported outcomes comparable or superior to xenograft bone combined with a collagen membrane in the regenerative treatment of mandibular molar Class II furcation defects.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 years or older.

Full-mouth plaque score (FMPS) ≤ 20%.

Full-mouth bleeding score (FMBS) ≤ 20%.

Willingness to participate in the study and provide informed consent.

Disqualifiers

Systemic diseases or conditions that may affect periodontal treatment outcomes, including uncontrolled diabetes mellitus, heart disease requiring anticoagulant therapy, hematologic disorders, or immunodeficiency.

Pregnancy or breastfeeding.

Untreated endodontic pathology involving the study tooth.

Class III furcation involvement according to the Hamp classification.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Periodontal Regenerative Surgery With Xenograft and Enamel Matrix Derivative

    Procedure/Surgery

    Periodontal regenerative surgery is performed using xenograft bone combined with enamel matrix derivative (EMD). After flap elevation, thorough defect debridement, and root surface conditioning with 24% EDTA for 2 minutes, EMD is applied to the root surface associated with the furcation defect. The xenograft bone is mixed with EMD and placed to completely fill the defect. The flap is then repositioned and sutured.

  • Periodontal Regenerative Surgery With Xenograft and Collagen Membrane

    Procedure/Surgery

    Periodontal regenerative surgery is performed using xenograft bone combined with a resorbable collagen membrane. After flap elevation, thorough defect debridement, and root surface conditioning with 24% EDTA for 2 minutes, the xenograft bone is mixed with sterile saline and placed to completely fill the furcation defect. A trimmed resorbable collagen membrane is positioned to completely cover the defect and secured before flap repositioning and suturing.

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Xenograft + Enamel Matrix DerivativeExperimental treatment 1 intervention
Group B: Xenograft + Collagen MembraneActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Probing Pocket Depth (PPD)

Probing pocket depth (PPD) is measured in millimeters from the gingival margin to the base of the periodontal pocket using a UNC-15 periodontal probe at the mesiobuccal, buccal, and distobuccal sites of the treated tooth. Measurements are standardized using an individualized acrylic stent. The change in PPD from baseline to 6 months after surgery will be compared between the two treatment groups.

Time frame
Baseline and 6 months after surgery
2

Change in Horizontal Clinical Attachment Loss (HCAL)

Horizontal clinical attachment loss (HCAL) is measured in millimeters from the buccal entrance of the furcation to the deepest horizontal point of the furcation defect using a Nabers periodontal probe and an individualized acrylic stent.

Time frame
Baseline and 6 months after surgery

Secondary outcomes

1

Change in Vertical Clinical Attachment Loss (VCAL)

Time frame
Baseline and 6 months after surgery
2

Change in Buccal Gingival Recession (REC)

Time frame
Baseline, 3 months, and 6 months after surgery
3

Change in Plaque Index (PI)

Time frame
Baseline, 3 months, and 6 months after surgery
4

Change in Gingival Index (GI)

Time frame
Baseline and 6 months after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.